Thermo Fisher Scientific Shares Sold by DAVENPORT & Co LLC

Institutional investor trims stake in medical research company

Mar. 28, 2026 at 8:07am

Got story updates? Submit your updates here. ›

DAVENPORT & Co LLC, an investment management firm, reduced its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 87.3% during the fourth quarter, according to a recent 13F filing with the SEC. The firm now owns 5,070 shares of the medical research company's stock, down from 39,887 shares previously.

Why it matters

Thermo Fisher Scientific is a major player in the medical research and laboratory equipment industry. Changes in institutional ownership of the company's stock can provide insights into broader market trends and investor sentiment around the firm's performance and outlook.

The details

According to the 13F filing, DAVENPORT & Co LLC sold 34,817 shares of Thermo Fisher Scientific during the fourth quarter. The firm's remaining stake in the company is now valued at $2.94 million. Thermo Fisher Scientific's stock price has fluctuated in recent months, with shares trading between $385.46 and $643.99 over the past 52 weeks.

  • DAVENPORT & Co LLC filed the 13F report disclosing the stake reduction in the fourth quarter of 2025.
  • The firm's previous 13F filing showed it owned 39,887 shares of Thermo Fisher Scientific.

The players

DAVENPORT & Co LLC

An investment management firm that has reduced its stake in Thermo Fisher Scientific.

Thermo Fisher Scientific Inc.

A global provider of scientific instrumentation, reagents, and services that support research, clinical, and industrial laboratories.

Got photos? Submit your photos here. ›

The takeaway

The reduction in DAVENPORT & Co LLC's position in Thermo Fisher Scientific reflects broader market trends and investor sentiment around the medical research company. However, the stock remains a holding of the institutional investor, suggesting continued confidence in the firm's long-term prospects.